Valeant Pharmaceuticals International Inc (NYSE:VRX)

197.84
Delayed Data
As of Mar 27
 -0.62 / -0.31%
Today’s Change
106.00
Today|||52-Week Range
206.84
+38.24%
Year-to-Date

Today’s Trading

Previous close198.46
Today’s open198.22
Day’s range196.56 - 200.31
Volume1,016,932
Average volume (3 months)3,135,290
Market cap$66.0B
Dividend yield--
Data as of 4:00pm ET, 03/27/2015

Growth & Valuation

Earnings growth (last year)--
Earnings growth (this year)+26.21%
Earnings growth (next 5 years)+26.30%
Revenue growth (last year)+43.22%
P/E ratio74.0
Price/Sales5.83
Price/Book12.45

Competitors

 Today’s
change
Today’s
% change
ABTAbbott Laboratories+0.28+0.60%
LLYEli Lilly and Co+0.14+0.19%
SHPGShire+2.47+1.04%
AZNAstraZeneca+0.30+0.43%
Data as of 4:06pm ET, 03/27/2015

Financials

Next reporting dateApril 30, 2015
EPS forecast (this quarter)$2.31
Annual revenue (last year)$8.3B
Annual profit (last year)$913.5M
Net profit margin11.05%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
Chairman &
Chief Executive Officer
J. Michael Pearson
Chief Financial Officer, Director &
Executive VP
Howard Bradley Schiller
Corporate headquarters
Laval, Quebec

Forecasts

To view my watchlist

Not a member yet?

Sign up now for a free account